Skip to main content
VulnerabilityPublished

CVE-2026-0304: Palo Alto Networks Cortex XDR Broker VM · Argument Injection

Affects Palo Alto Networks Cortex XDR Broker VMSource CVE Database V5

0

Not known to be exploited · CVSS 4.8 Medium : upgrade to 32.0.52 when convenient.

Data as of 26 Oct 2026, 12:55 UTC

CVSS 4.0 base score
4.8Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 27% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CISA SSVC
Exploitation
No evidence of active exploitation and no public proof of concept
Automatable
Attackers cannot reliably automate steps 1–4 of the kill chain
Technical impact
Total control over the software or total information disclosure

CISA SSVC assessment, 2026-09-10.

Patch
Available – fixed in 32.0.52
CVSS:4.0/AV:A/AC:L/AT:P/PR:L/UI:N/VC:H/VI:H/VA:H/SC:L/SI:L/SA:L/E:U/AU:N/R:U/V:D/RE:M/U:Amber

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 10 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponised: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.

What to do

Upgrade Palo Alto Networks Cortex XDR Broker VM to 32.0.52.

Affected software

ProductAffectedFixed in
Palo Alto NetworksCortex XDR Broker VMAffected
  • >=20.0.96 <32.0.52
Fixed in
  • 32.0.52

Description

A privilege escalation vulnerability in Palo Alto Networks Cortex XDR Broker VM enables an authenticated low privileged user with man-in-the-middle (MitM) access to execute code with root privileges on the Broker VM.

References

Community reviews

Loading reviews…